Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
DRGX | hg38_v1_chr10_-_49396074_49396098 | 0.09 | 6.1e-01 | Click! |
PROP1 | hg38_v1_chr5_-_177996242_177996242 | 0.05 | 8.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_68106109 Show fit | 5.80 |
ENST00000540630.5
ENST00000354393.6 |
myopalladin |
|
chr15_+_48191648 Show fit | 4.43 |
ENST00000646012.1
ENST00000561127.5 ENST00000647546.1 ENST00000559641.5 ENST00000417307.3 |
solute carrier family 12 member 1 cortexin 2 |
|
chr4_+_154563003 Show fit | 4.31 |
ENST00000302068.9
ENST00000509493.1 |
fibrinogen beta chain |
|
chr10_-_60141004 Show fit | 2.56 |
ENST00000355288.6
|
ankyrin 3 |
|
chr4_-_175812746 Show fit | 2.52 |
ENST00000393658.6
|
glycoprotein M6A |
|
chr1_-_151175966 Show fit | 2.40 |
ENST00000441701.1
ENST00000295314.9 |
tropomodulin 4 |
|
chr8_+_66126896 Show fit | 2.36 |
ENST00000353317.9
|
tripartite motif containing 55 |
|
chr5_+_137867868 Show fit | 2.17 |
ENST00000515645.1
|
myotilin |
|
chrX_-_55182442 Show fit | 2.03 |
ENST00000545075.3
|
MT-RNR2 like 10 |
|
chr2_-_182427014 Show fit | 1.95 |
ENST00000409365.5
ENST00000351439.9 |
phosphodiesterase 1A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 6.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 5.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.6 | 4.5 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.3 | 4.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 3.7 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 3.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 3.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.9 | 2.6 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.3 | 2.4 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
0.2 | 2.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 10.3 | GO:0030018 | Z disc(GO:0030018) |
0.4 | 5.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 4.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 3.3 | GO:0016605 | PML body(GO:0016605) |
0.0 | 3.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 3.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 2.7 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 2.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.9 | 2.6 | GO:0098831 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
0.2 | 2.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 4.5 | GO:0030507 | spectrin binding(GO:0030507) |
1.5 | 4.4 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.0 | 4.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 3.7 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 3.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 2.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 2.6 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 2.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 2.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 3.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 1.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 4.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 4.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 4.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 3.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 3.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 2.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 2.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |